AVTX icon

Avalo Therapeutics

21 hedge funds and large institutions have $9.62M invested in Avalo Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$6.72M
2 +$764K
3 +$499K
4
AAA
Affinity Asset Advisors
New York
+$436K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$129K

Top Sellers

1 -$131K
2 -$54.6K
3 -$51.5K
4
TRCT
Tower Research Capital (TRC)
New York
-$35.7K
5
BlackRock
BlackRock
New York
-$22.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.72M
2
$891K
3
$682K
4
$561K
5
$499K
6
$129K
7
$69.8K
8
$44.7K
9
$7K
10
$4.1K
11
$4K
12
$124
13
$50
14
$25
15
$25
16
$25
17
$24
18
$12
19
$12
20
$12
21
$12
22
23
24
25